Is the recurrence rate of chronic subdural hematomas dependent on the duration of drainage?

Aydemir Kale1, İbrahim İlker Öz2, Eren Görkem Gün1

  • 1a Faculty of Medicine, Department of Neurosurgery , Bülent Ecevit University , Zonguldak , Turkey.

Neurological Research
|February 23, 2017
PubMed

Insights

Longer closed-system drainage after burr hole craniotomy for chronic subdural hematoma (CSDH) significantly reduces recurrence rates. Extending drainage to 5-7 days is more effective than 2-4 days without increasing complications.

Area of Science:

  • Neurosurgery
  • Neurology
  • Medical Devices

Background:

  • Chronic subdural hematoma (CSDH) is a common intracranial hemorrhage, particularly in the elderly.
  • Optimal surgical treatment for CSDH remains debated.
  • Burr hole craniotomy with closed-system drainage is a standard CSDH treatment.

Purpose of the Study:

  • To investigate the impact of prolonged closed-system drainage duration on CSDH treatment outcomes.
  • To compare recurrence rates and residual hematoma thickness between different drainage durations.
  • To evaluate the safety and efficacy of extended drainage in CSDH management.

Main Methods:

  • A retrospective study of 105 CSDH cases treated between 2008 and 2016.
  • Patients were divided into two groups: 2-4 days (Group A, n=40) and 5-7 days (Group B, n=50) of closed-system drainage.
  • Recurrence was defined as symptomatic hematoma re-accumulation within six months post-surgery.

Main Results:

  • Recurrence rates were significantly lower in the longer drainage group (3.3% in Group B vs. 15.6% in Group A, p=0.04).
  • Postoperative residual hematoma thickness was also significantly reduced with longer drainage (p=0.05).
  • No increase in complications was noted with extended drainage duration.

Conclusions:

  • Closed-system drainage for 2-4 days is effective for CSDH.
  • Extending drainage duration to 5-7 days offers improved outcomes, including reduced recurrence and residual hematoma.
  • Longer drainage periods represent a safe and more effective treatment strategy for CSDH.
Abstract